Rollins opened higher at $35.43, compared with its previous close of $34.69. In the last trading session, the stock traded between $34.70 and $35.56. It showed a sideways intraday trend.
An investment of $100 made 5 years ago in Rollins is now worth
$ 98.70
resulting in a loss of
$ 1.30 (1.30%)
Note: Past profits do not guarantee future returns.
Rating from 14 Analysts
Today's Change
+$0.08 (+0.23%)
Day High
$35.56
Day Low
$34.70
Day Open
$35.43
Prev Close
$34.69
Volume
15,23,558
1W Return
-1.49%
1M Return
14.05%
3M Return
-10.32%
6M Return
-37.16%
1Y Return
-35.45%
Market Cap ($ Mn)
16,622
PE Ratio
33.14
PB Ratio
12.24
PEG Ratio
3.40
ROE
37.43%
ROCE
31.07%
EPS (TTM)
$0.33
1 Week
-1.49%
1 Month
14.05%
3 Months
-10.32%
6 Months
-37.16%
9 Months
-44.83%
Rollins Q3 Results: Revenue up 6% to $1.09B, misses estimate
Adjusted EPS stood at $0.34, meeting consensus but declining 2.86% YoY. Quarterly revenue reached $1.090 billion, up 6.24% YoY. Revenue missed the analyst estimate of $1.106 billion by 1.45%. Top-line growth did not translate to bottom-line improvement, with EPS falling.
8 days agoCanaccord Genuity cuts Rollins price target to $36, keeps Hold rating
Canaccord Genuity maintains Hold rating on Rollins Inc. Price target lowered from $45 to $36 by analyst Brian McNamara. Target aligns with UBS's recent cut to $36. Morgan Stanley retains Overweight with a higher $43 target.
11 days agoRollins to present at J.P. Morgan All Stars Conference
Rollins CEO Jerry Gahlhoff and CFO William Harkins to present at J.P. Morgan conference. Presentation scheduled for September 23, 2026, from 10:00 am to 10:45 am ET. Event will be held at London J.P. Morgan headquarters and webcast live. Replay available for 180 days on company investor relations site.
1mo agoRollins Inc faces investor probe after Q2 margin slip
Pomerantz LLP investigates Rollins Inc for potential securities fraud. Q2 FY26 operating margin fell 110 bps to 18.7%. Operating cash flow declined 1.5% YoY to $173 million. Stock dropped 9.27% to $39.44 after earnings miss.
2mo agoBragar Eagel & Squire joins probe into Rollins Inc securities fraud
Bragar Eagel & Squire, P.C. joins Pomerantz LLP in probing Rollins, Inc. for potential securities fraud following a significant Q2FY26 earnings miss. The investigation examines whether the company misled investors about its operational health, specifically regarding a 110 basis point drop in operating margins to 18.7% and a 1.5% decline in operating cash flow. CEO Jerry Gahlhoff blamed a worsening digital lead environment for the shortfall, but the market reacted sharply, sending shares down 9.27% to $39.44. The dual investigations heighten legal risks for Rollins as shareholders seek recourse for losses incurred during the earnings release period.
2mo agoAnalysts downgrade Rollins, Zions, WesBanco on Thursday
Five stocks faced analyst downgrades on Thursday, led by Rollins Inc and Zions Bancorporation. Curtis Nagle cut Rollins' target to $35, while John Pancari lowered Zions' target to $68. Other downgrades included WesBanco Inc, Pegasystems Inc, and Agilon Health Inc, with mixed implications for near-term price targets.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $75.17 | -8.70% | $10,269.65M | 21.82 | |
| $49.68 | +3.93% | $6,085.45M | 9.22 | |
| $87.35 | +3.74% | $6,017.80M | 21.87 | |
| $66.98 | -3.33% | $3,257.57M | 23.67 | |
| $64.87 | +3.08% | $883.08M | 18.16 | |
| $35.44 | -2.74% | $562.86M | 12.18 | |
| $12.26 | -0.16% | $137.10M | - | |
| $29.78 | +1.15% | $74.45M | 0.60 | |
| $0.67 | -2.61% | $4.97M | - | |
| $0.35 | -3.24% | $2.73M | 2.38 |
An investment of $100 made 5 years ago in Rollins is now worth
$ 98.70
resulting in a loss of
$ 1.30 (1.30%)
Note: Past profits do not guarantee future returns.
